MAPT and Alzheimer disease: Although our findings provide indirect evidence that anxiety is an outcome of Aβ accumulation, bidirectional and longitudinal analyses are necessary to define these causal relationships, the role of related pathologies such as soluble Aβ and tau, and possible involvement of neuroinflammatory processes, in the pathogenesis of anxiety symptoms during preclinical AD.